Glenmark Pharma plans US clinical trials on biological drug

Written by:
Subscribe to Oneindia News

New Delhi, Sep 11 (UNI) Glenmark Pharmaceuticals today said it has filed for approval to start initial stage clinical trials of experimental biological drug GBR 500 with the US Food and Drug Administration (US FDA).

The drug is a monoclonal antibody, which Glenmark hopes to initially develop as a treatment for multiple sclerosis.

The company expects to complete the trials in the current financial year, it said in a statement.


Please Wait while comments are loading...